Cargando…
The comparison of effectiveness of therapy with ustekinumab and etanercept in psoriatic patients during 48 weeks’ observation
Autores principales: | Wcisło-Dziadecka, Dominika, Grabarek, Beniamin, Gola, Joanna, Plewka, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362776/ https://www.ncbi.nlm.nih.gov/pubmed/34408588 http://dx.doi.org/10.5114/ada.2021.104295 |
Ejemplares similares
-
Ustekinumab therapy changes the transcriptional activity pattern of TGF-β1–3 genes
por: Grabarek, Beniamin, et al.
Publicado: (2020) -
Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2020) -
In silico analysis of CpG islands and miRNAs potentially regulating the JAK-STAT signalling pathway
por: Grabarek, Beniamin O., et al.
Publicado: (2020) -
Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2020) -
Effect of adalimumab on the expression of genes encoding TNF-α signal paths in skin fibroblasts in vitro
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2018)